Advances in Cancer Immunotherapy™️ Webinar: Clinical Updates from ESMO Immuno-Oncology Congress 2020

When:  Jul 16, 2021 from 12:00 to 13:00 (ET)

On July 16, 2021 at 12:00 pm ET, join Paolo A. Ascierto, MD and other leading experts in cancer immunotherapy as they discuss the latest and most exciting clinical updates emerging from ESMO Immuno-Oncology Virtual Congress 2020.

This FREE, CME-, CNE-, CPE- and MOC- certified webinar is a chance for clinical oncologists, registered nurses, nurse practitioners, advanced practice registered nurses, pharmacists, physician assistants, emergency physicians, allied health professionals, other patient care providers, students, and patient advocates, to learn about key clinical implications from select ESMO IO 2020 presentations.

This live webinar will also feature a dedicated question and answer session to address your questions about clinical applications of cancer immunotherapy. Don't miss this opportunity to continue learning about the expanding cancer immunotherapy field!

REGISTER NOW

Featured presentations: 

  • A Phase (ph) 2, Multi-Center Study of the Safety and Efficacy of tebentafusp (tebe) (IMCgp100) in Patients (pts) with Metastatic Uveal Melanoma (mUM) - Presenter: Joseph Sacco, MBChB, MSc, MRCP, PhD
  • A phase I clinical trial on intratumoral (IT) administration of ipilimumab (IPI) plus nivolumab (NIVO) followed by intracavitary (IC) administration of nivolumab in patients with recurrent glioblastoma - Julia Katharina Schwarze, MD, MSc
  • Additional clinical abstracts of interest from ESMO Immuno-Oncology Congress 2020 will be presented by Sunandana Chandra, MD, MS

Webinar Faculty:
  • Moderator: Paolo A. Ascierto, MD – Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale'
  • Presenters:
    • Sunandana Chandra, MD, MS – Northwestern University
    • Joseph Sacco, MBChB, MSc, MRCP, PhD – The Clatterbridge Cancer Centre
    • Julia Katharina Schwarze, MD, MSc – University Hospital Brussels


Webinar Agenda:

  • 12-12:05 p.m. ET  Overview: welcome and introductions
  • 12:05-12:45 p.m. ET  Presentation and discussion of content from faculty experts
  • 12:45-12:55 p.m. ET  Question and answer session
  • 12:55-1 p.m. ET  Closing remarks

Continuing Education Credit Information:
Continuing Education Credits are available for physicians, nurses, and pharmacists. To view full accreditation information, click here.


The 2020-2021 ACI series is jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.
  
The 2020-2021 Advances in Cancer Immunotherapy™ series is brought to you in collaboration with the American Academy of Emergency Medicine, the Association of Community Cancer Centers and the Hematology/Oncology Pharmacy Association.

The 2020–2021 Advances in Cancer Immunotherapy™ educational series is supported, in part, by independent medical education grants from Amgen, AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, Exelixis, Inc. and Merck & Co., Inc.